References
1. World Health Organization (WHO): What is a pandemic? Accessed on 2-2010). Found at: https://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/en/.
2. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents.Nat Rev Microbiol. 2005;3:591-600. doi: 510.1038/nrmicro1208.
3. Morens DM, Taubenberger JK. The Mother of All Pandemics Is 100 Years Old (and Going Strong)!Am J Public Health. 2018;108:1449-1454. doi: 1410.2105/AJPH.2018.304631. Epub 302018 Sep 304625.
4. Yang Y, Peng F, Wang R, et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun.2020;109:102434.:10.1016/j.jaut.2020.102434. Epub 102020 Mar 102433.
5. World Health Organization (WHO): Rolling updates on coronavirus disease (COVID-19). Accessed on 5-2020. Found at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen.
6. Sohrabi C, Alsafi Z, O’Neill N, et al. Corrigendum to ”World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)” [Int. J. Surg. 76 (2020) 71-76]. Int J Surg. 2020;15:036.
7. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.
8. Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. The Lancet.
9. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497-506.
10. World Health Organization. Coronavirus disease (COVID-19) advice for the public. Accessed on 5-2020. Found at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public.
11. Corkill NL. Epidemic smallpox in Jiddah; treatment with antibiotics. Br Med J.1951;2:663-667. doi: 610.1136/bmj.1132.4732.1663.
12. Scrimgeour EM. Epidemic infections and their relevance to the Gulf and other Arabian Peninsula countries. J Sci Res Med Sci. 2003;5:1-4.
13. Memish ZA, Venkatesh S, Ahmed QA. Travel epidemiology: the Saudi perspective. Int J Antimicrob Agents. 2003;21:96-101. doi: 110.1016/s0924-8579(1002)00364-00363.
14. Basheti IA, Nassar R, Barakat M, et al. Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm. 2020;23:30418-30416.
15. Sokolow LZ, Patel A, Koonin LM, Graitcer SB. Scripted Surge Pharmacy Pandemic Exercise: Testing Vaccine Administration and Antiviral Dispensing. Health Secur. 2018;16:262-273. doi: 210.1089/hs.2018.0031.
16. Rosenfeld LA, Etkind P, Grasso A, Adams AJ, Rothholz MC. Extending the reach: local health department collaboration with community pharmacies in Palm Beach County, Florida for H1N1 influenza pandemic response. J Public Health Manag Pract. 2011;17:439-448. doi: 410.1097/PHH.1090b1013e31821138ae.
17. SteelFisher GK, Benson JM, Caporello H, et al. Pharmacist Views on Alternative Methods for Antiviral Distribution and Dispensing During an Influenza Pandemic.Health Secur. 2018;16:108-118. doi: 110.1089/hs.2017.0068. Epub 2018 Mar 1023.
18. Nazar Z, Nazar H. Exploring the experiences and preparedness of humanitarian pharmacists in responding to an emergency-response situation. Res Social Adm Pharm. 2020;16:90-95. doi: 10.1016/j.sapharm.2019.1003.1146. Epub 2019 Mar 1031.
19. Song Z, Hu Y, Zheng S, Yang L, Zhao R. Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Res Social Adm Pharm. 2020;3:30314-30314.
20. Khan Z, Muhammad K, Ahmed A, Rahman H. Coronavirus outbreaks: prevention and management recommendations. Drugs & Therapy Perspectives. 2020:1-3.
21. Gross AE, MacDougall C. Roles of the clinical pharmacist during the COVID‐19 pandemic.Journal of the American colledge of clinical pharmacy 2020:1-3.
22. Miller S, Patel N, Vadala T, Abrons J, Cerulli J. Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc (2003). 2012;52:763-767. doi: 710.1331/JAPhA.2012.11003.
23. McCourt E. Improving pharmacist involvement in pandemic influenza planning and response in Australia. Found at https://ahha.asn.au/system/files/docs/publications/summary_deeble_institute_issues_brief_no._25.pdf. Accessed 4, 2020. Australian Healthcare and Hospital Association.2018.
24. Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 2020;26:30284-30289.
25. WHO Coronavirus Disease (COVID-19) Dashboard. Accessed on May-2020. Found at https://covid19.who.int/.
26. Hernandez-Garcia I, Gimenez-Julvez T. Assessment of Health Information About COVID-19 Prevention on the Internet: Infodemiological Study. JMIR Public Health Surveill. 2020;6:e18717. doi: 18710.12196/18717.
27. Karasneh R, Al-Azzam S, Muflih S, Soudah O, Hawamdeh S, Khader Y. Media’s effect on shaping knowledge, awareness risk perceptions and communication practices of pandemic COVID-19 among pharmacists. Res Social Adm Pharm. :.10.1016/j.sapharm.2020.1004.1027.
28. Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. 2020;368:m1086.
29. FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems. Cited on 4-2020/ Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or.
30. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. Jama. 2020;13.
31. Le Bourgeois M, Ferroni A, Leruez-Ville M, et al. Nonsteroidal Anti-Inflammatory Drug without Antibiotics for Acute Viral Infection Increases the Empyema Risk in Children: A Matched Case-Control Study. J Pediatr.2016;175:47-53.e3.:10.1016/j.jpeds.2016.1005.1025. Epub 2016 Jun 1020.
32. Capuano A, Scavone C, Racagni G, Scaglione F. NSAIDs in patients with viral infections, including Covid-19: victims or perpetrators? Pharmacol Res.2020;29:104849.
33. Alobaedi OH, Talib WH, Basheti IA. Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pac J Trop Med.2017;10:400-408. doi: 410.1016/j.apjtm.2017.1003.1026. Epub 2017 Apr 1017.
34. Lima CKT, Carvalho PMM, Lima I, et al. The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease). Psychiatry Res.2020;287:112915.:10.1016/j.psychres.2020.112915.
35. Walton M, Murray E, Christian MD. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic. Eur Heart J Acute Cardiovasc Care. 2020;28:2048872620922795.
36. FIP. Coronavirus SARS-CoV-2 / COVID-19 pandemic: Information and Guidelines for Pharmacists and the Pharmacy Workforce Vol 2020. The Netherlands: International Pharmaceutical Federation 2020.
37. Nazer LH, Tuffaha H. Health Care and Pharmacy Practice in Jordan. Can J Hosp Pharm.2017;70:150-155. doi: 110.4212/cjhp.v4270i4212.1649. Epub 2017 Apr 4228.
38. Tyrer S, Heyman B. Sampling in epidemiological research: issues, hazards and pitfalls.BJPsych Bull. 2016;40:57-60. doi: 10.1192/pb.bp.1114.050203.
39. Nelson LM, Simard JF, Oluyomi A, et al. US Public Concerns About the COVID-19 Pandemic From Results of a Survey Given via Social Media. JAMA Intern Med.2020;7.
40. Bates I, Bader LR, Galbraith K. A global survey on trends in advanced practice and specialisation in the pharmacy workforce. Int J Pharm Pract.2020;28:173-181. doi: 110.1111/ijpp.12611.